NEW YORK, May 18 - Nanogen is gearing up to launch its first clinical diagnostic products and to see its revenues from product sales increase substantially this year, Kieran Gallahue, the company's president said Friday.

We are accelerating the march to clinical diagnostics," Gallahue told GenomeWeb. "Right now we're selling to clinical researchers, then the next stage is to sell to clinical labs and then to various sized hospitals."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.